Depression and resilience: Insights from cognitive, neuroimaging, and psychopharmacological studies

Decision Making, Affect, and Learning: Attention and Performance XXIII

Volumn , Issue , 2011, Pages

  Sahakian, Barbara J ^a,b   Morein Zamir, Sharon ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bipolar disorder; Depression; Major depressive disorder; Mania; Mood; Resilience

Indexed keywords

EID: 84921630352     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780199600434.003.0023     Document Type: Chapter

References (136)

1. Abas, M. A., Sahakian, B. J., and Levy, R. (1990). Neuropsychological deficits and CT scan changes in elderly depressives. Psychological Medicine, 20(3), 507-20.
2. Ackerman, D. L., Unutzer, J., Greenland, S., and Gitlin, M. (2002). Inpatient treatment of depression and associated hospital charges. Pharmacoepidemiol Drug Saf, 11(3), 219-27.
3. APA. (2000). Diagnostic and statistical manual-IV (text revision). Washington, DC:American Psychiatric Associations.
4. Beats, B. C., Sahakian, B. J., and Levy, R. (1996). Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychological Medicine, 26(3), 591-603.
5. Beck, A. T. (1967). Depression: clinical experimental and theoretical aspects. New York: Harper and Row.
6. Beck, A. T. (1976). Cognitive therapy and the emotional disorders. New York:International Universities Press.
7. Beddington, J., Cooper, C. L., Field, J., Goswami, U., Huppert, F. A., Jenkins, R. et al. (2008). The mental wealth of nations. Nature, 455(7216), 1057-60.
8. Bell, C. J., Hood, S. D., and Nutt, D. J. (2005). Acute tryptophan depletion. Part II:clinical effects and implications. Australian and New Zealand Journal of Psychiatry, 39(7), 565-74.
9. Bell-McGinty, S., Butters, M. A., Meltzer, C. C., Greer, P. J., Reynolds, C. F., 3rd, and Becker, J. T. (2002). Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. American Journal of Psychiatry, 159(8), 1424-27.
10. Booij, L., Van der Does, A. J., and Riedel, W. J. (2003). Monoamine depletion in psychiatric and healthy populations: review. Molecular Psychiatry, 8(12), 951-73.
11. Booij, L., Van der Does, A. J., Haffmans, P. M., Riedel, W. J., Fekkes, D., and Blom, M. J. (2005). The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. Journal of Psychopharmacology, 19(3), 267-75.
12. Borkowska, A. and Rybakowski, J. K. (2001). Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disorder, 3(2), 88-94.
13. Bowley, M. P., Drevets, W. C., Ongur, D., and Price, J. L. (2002). Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry, 52(5), 404-12.
14. Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., and Charney, D. S. (2000). Hippocampal volume reduction in major depression. American Journal of Psychiatry, 157(1), 115-118.
15. Bremner, J. D., Vythilingam, M., Vermetten, E., Nazeer, A., Adil, J., Khan, S. et al. (2002). Reduced volume of orbitofrontal cortex in major depression. Biological Psychiatry, 51(4), 273-79.
16. Brittlebank, A. D., Scott, J., Williams, J. M., and Ferrier, I. N. (1993). Autobiographical memory in depression: state or trait marker? British Journal of Psychiatry, 162, 118-21.
17. Campbell, S., Marriott, M., Nahmias, C., and MacQueen, G. M. (2004). Lower hippocampal volume in patients suffering from depression: a meta-analysis. American Journal of Psychiatry, 161(4), 598-607.
18. Canli, T. and Lesch, K. P. (2007). Long story short: the serotonin transporter in emotion regulation and social cognition. Nature Neuroscience, 10(9), 1103-109.
19. Cannon, D. M., Klaver, J. M., Peck, S. A., Rallis-Voak, d., Erickson, K., and Drevets, W. C. (2009). Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]NNC-112. Neuropsychopharmacology, 34, 1277-87.
20. Carpenter, L. L., Anderson, G. M., Pelton, G. H., Gudin, J. A., Kirwin, P. D., Price, L. H. et al. (1998). Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology, 19(1), 26-35.
21. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H. et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386-89.
22. Chamberlain, S. R. and Sahakian, B. J. (2004). Cognition in mania and depression:psychological models and clinical implications. Current Psychiatry Report, 6(6), 451-58.
23. Chamberlain, S. R. and Sahakian, B. J. (2005). Nueropsychological assessment of mood disorders. Clinical Neuropsychiatry, 2(3), 137-48.
24. Chamberlain, S. R., Muller, U., Blackwell, A. D., Clark, L., Robbins, T. W., and Sahakian, B. J. (2006). Neurochemical modulation of response inhibition and probabilistic learning in humans. Science, 311(5762), 861-63.
25. Clark, L., Iversen, S. D., and Goodwin, G. M. (2002). Sustained attention deficit in bipolar disorder. Br J Psychiatry, 180, 313-19.
26. Clark, L., Chamberlain, S. R., and Sahakian, B. J. (2009). Neruocognitive mechanisms in depression: implications for treatment. Annual Review of Neuroscience, 32, 57-74.
27. Clark, L. and Sahakian, B. J. (2006). Neuropsychological and biological approaches to understanding bipolar disorder. Oxford University Press.
28. Clark, L. and Sahakian, B. J. (2008). Cognitive neuroscience and brain imaging in bipolar disorder. Dialogues in Clinical Neuroscience, 10(2), 153-63.
29. Conway, M., Howell, A., and Giannopoulos, C. (1991). Dysphoria and thought suppression. Cognitive Therapy and Research, 15, 153-66.
30. Cools, R., Clark, L., Owen, A. M., and Robbins, T. W. (2002). Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neuroscience, 22(11), 4563-67.
31. Cools, R., Blackwell, A., Clark, L., Menzies, L., Cox, S., and Robbins, T. W. (2005). Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology, 30(7), 1362-73.
32. Cools, R., Robinson, O.J., and Sahakian, B. (2008). Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology, 33(9), 2291-99.
33. Coppen, A., Prange, A. J., Jr., Whybrow, P. C., and Noguera, R. (1972). Abnormalities of indoleamines in affective disorders. Archives of General Psychiatry, 26(5), 474-78.
34. Cotter, D., Mackay, D., Landau, S., Kerwin, R., and Everall, I. (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry, 58(6), 545-53.
35. Cowen, P. J. (1990). A role for 5-HT in the action of antidepressant drugs. Pharmacological Therapy, 46, 43-51.
36. Delgado, P. L., Charney, D. S., Price, L. H., Aghajanian, G. K., Landis, H., and Heninger, G. R. (1990). Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry, 47(5), 411-18.
37. DeRubeis, R. J., Siegle, G. J., and Hollon, S. D. (2008). Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nature Review Neuroscience, 9(10), 788-96.
38. Dougherty, D. D., Bonab, A. A., Ottowitz, W. E., Livini, E., Alpert, N. M., Rauch S. L. et al. (2006). Decreased striatal D1 binding as measured using PET and [11C]SCH 23, 390 in patients with major depression with anger attacks. Depression and Anxiety, 23(3), 175-7.
39. Drevets, W. C. (1999). Prefrontal cortical-amygdalar metabolism in major depression. Annals of the NY Academy of Science, 877, 614-37.
40. Drevets, W. C., Price, J. L., Simpson, J. R., Jr., Todd, R. D., Reich, T., Vannier, M. et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386(6627), 824-27.
41. Drevets, W. C., Ongur, D., and Price, J. L. (1998). Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Molecular Psychiatry, 3(3), 220-26, 190-21.
42. Drevets, W. C., Price, J. L., and Furey, M. L. (2008a). Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function, 213(1-2), 93-118.
43. Drevets, W. C., Savitz, J., and Trimble, M. (2008b). The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums, 13(8), 663-81.
44. Elliott, R., Sahakian, B. J., McKay, A. P., Herrod, J. J., Robbins, T. W., and Paykel, E. S. (1996). Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychological Medicine, 26(5), 975-89.
45. Elliott, R., Sahakian, B. J., Herrod, J. J., Robbins, T. W., and Paykel, E. S. (1997a). Abnormal response to negative feedback in unipolar depression: evidence for a diagnosis specific impairment. Journal of Neurology Neurosurgery Psychiatry, 63(1), 74-82.
46. Elliott, R., Baker, S. C., Rogers, R. D., O'Leary, D. A., Paykel, E. S., Frith, C. D. et al. (1997b). Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychological Medicine, 27(4), 931-42.
47. Elliott, R., Rubinsztein, J. S., Sahakian, B. J., and Dolan, R. J. (2000). Selective attention to emotional stimuli in a verbal go/no-go task: an fMRI study. Neuroreport, 11(8), 1739-44.
48. Elliott, R., Rubinsztein, J. S., Sahakian, B. J., and Dolan, R. J. (2002). The neural basis of mood-congruent processing biases in depression. Archives of General Psychiatry, 59(7), 597-604.
49. Elliott, R., Ogilvie, A., Rubinsztein, J. S., Calderon, G., Dolan, R. J., and Sahakian, B. J. (2004). Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biological Psychiatry, 55(12), 1163-70.
50. Erickson, K., Drevets, W. C., Clark, L., Cannon, D. M., Bain, E. E., Zarate, C. A., Jr. et al. (2005). Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. American Journal of Psychiatry, 162(11), 2171-73.
51. Evers, E. A., Cools, R., Clark, L., van der Veen, F. M., Jolles, J., Sahakian, B. J. et al. (2005). Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology, 30(6), 1138-47.
52. Furlong, R. A., Rubinsztein, J. S., Ho, L., Walsh, C., Coleman, T. A., Muir, W. J. et al. (1999). Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. American Journal of Medical Genetics, 88(1), 88-94.
53. Goldberg, T. E., Gold, J. M., Greenberg, R., Griffin, S., Schulz, S. C., Pickar, D. et al. (1993). Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. American Journal of Psychiatry, 150(9), 1355-62.
54. Gotlib, I. H. (1983). Perception and recall of interpersonal feedback: negative bias in depression. Cognitive Therapy and Research, 7, 399-412.
55. Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A. et al. (2003). The economic burden of depression in the United States:how did it change between 1990 and 2000? Journal of Clinical Psychiatry, 64(12), 1465-75.
56. Harmer, C. J. (2008). Serotonin and emotional processing: Does it help explain antidepressant drug action? Neuropharmacology, 55, 1023-28.
57. Hasler, G., Fromm, S., Carlson, P. J., Luckenbaugh, D. A., Waldeck, T., Geraci, M. et al. (2008). Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry, 65(5), 521-31.
58. Hasler, G., Mondillo, K., Drevets, W. C., and Blair, J. R. (2009). Impairments of probabilistic response reversal and passive avoidance following catecholamine depletion. Neuropsychopharmacology, 34(13), 2691-8.
59. Hatzidimitriou, G., McCann, U. D., and Ricaurte, G. A. (1999). Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. Journal of Neuroscience, 19(12), 5096-107.
60. Hood, S. D., Bell, C. J., and Nutt, D. J. (2005). Acute tryptophan depletion. Part I:rationale and methodology. Australian and New Zealand Journal of Psychiatry, 39(7), 558-64.
61. Horn, G. (2008). Brain Science, addiction and drugs. The Academy of Medical Sciences.
62. Jaeger, J., Berns, S., Uzelac, S., and Davis-Conway, S. (2006). Neurocognitive deficits and disability in major depressive disorder. Psychiatric Research, 145(1), 39-48.
63. Johnson, M. H. and Magaro, P. A. (1987). Effects of mood and severity on memory processes in depression and mania. Psychological Bulletin, 101(1), 28-40.
64. Kennedy, S. H., Evans, K. R., Kruger, S., Mayberg, H. S., Meyer, J. H., McCann, S. et al. (2001). Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. American Journal of Psychiatry, 158(6), 899-905.
65. Kennedy, S. H., Konarski, J. Z., Segal, Z. V., Lau, M. A., Bieling, P. J., McIntyre, R. S. et al. (2007). Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry, 164(5), 778-88.
66. Kessing, L. V. (1998). Cognitive impairment in the euthymic phase of affective disorder. Psychological Medicine, 28(5), 1027-38.
67. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., and Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617-27.
68. Kyte, Z. A., Goodyer, I. M., and Sahakian, B. J. (2005). Selected executive skills in adolescents with recent first episode major depression. Journal of Child Psychology and Psychiatry and Allied Disciplines, 46(9), 995-1005.
69. Lawrence, A. D., Hodges, J. R., Rosser, A. E., Kershaw, A., ffrench-Constant, C., Rubinsztein, D. C. et al. (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121 (Pt 7), 1329-41.
70. Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., and Kennedy, S. H. (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry, 64(6), 461-67.
71. MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T. et al. (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Science USA, 100(3), 1387-92.
72. Martinez-Aran, A., Vieta, E., Colom, F., Torrent, C., Sanchez-Moreno, J., Reinares, M. et al. (2004). Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disorder, 6(3), 224-32.
73. Mayberg, H. S. (1997). Limbic-cortical dysregulation: a proposed model of depression. Journal of Neuropsychiatry and Clinical Neuroscience, 9(3), 471-81.
74. Mayberg, H. (2002). Depression, II: localization of pathophysiology. American Journal of Psychiatry, 159(12), 1979.
75. Mayberg, H. S. (2003). Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin North America, 13(4), 805-815.
76. Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L. et al. (1997). Cingulate function in depression: a potential predictor of treatment response. Neuroreport, 8(4), 1057-61.
77. Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C. et al. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45(5), 651-60.
78. McAllister-Williams, R. H., Massey, A. E., and Fairchild, G. (2007). Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers:evidence for desensitization of the 5-HT1A autoreceptor. Journal of Psychopharmacology, 21(8), 826-32.
79. McCann, U. D., Szabo, Z., Scheffel, U., Dannals, R. F., and Ricaurte, G. A. (1998). Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet, 352(9138), 1433-37.
80. McCrone, P., Dhanasiri, S., Patel, A., Knapp, M., and Lawton-Smith, S. (2008). Paying the Price: The Cost of Mental Health Care in England to 2026. Accessed April 1 2009 London: King's Fund.
81. McLean, A., Rubinsztein, J. S., Robbins, T. W., and Sahakian, B. J. (2004). The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (Berl), 171(3), 286-97.
82. Murphy, F. C., Sahakian, B. J., and O'Carroll, R. E. (1998). Cognitive impairment in depression: psychological models and clinical issues. In D. Ebert and K. P. Ebmeier (Eds.), New models for depression. Adv Biological Psychiatry (pp. 1-33). Basel: Karger.
83. Murphy, F. C., Sahakian, B. J., Rubinsztein, J. S., Michael, A., Rogers, R. D., Robbins, T. W. et al. (1999). Emotional bias and inhibitory control processes in mania and depression. Psychological Medicine, 29(6), 1307-21.
84. Murphy, F. C., Smith, K. A., Cowen, P. J., Robbins, T. W., and Sahakian, B. J. (2002). The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl), 163(1), 42-53.
85. Murphy, F. C., Michael, A., Robbins, T. W., and Sahakian, B. J. (2003). Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance. Psychological Medicine, 33(3), 455-67.
86. Neumeister, A., Konstantinidis, A., Stastny, J., Schwarz, M.J., Vitouch, O., Willeit, M. et al. (2002). Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Archives of General Psychiatry, 59, 613-20.
87. Neumeister, A., Nugent, A. C., Waldeck, T., Geraci, M., Schwarz, M., Bonne, O. et al. (2004). Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry, 61(8), 765-73.
88. Nutt, D. J. (2002). The neuropharmacology of serotonin and noradrenaline in depression. International Clinical Psycopharmacology, 17 Suppl 1, S1-12.
89. Nutt, D. J. (2006). The role of dopamine and norepinephrine in depression and antidepressant treatment. Journal of Clinical Psychiatry, 67, 3-8.
90. Ochsner, K. N., Bunge, S. A., Gross, J. J., and Gabrieli, J. D. (2002). Rethinking feelings: an FMRI study of the cognitive regulation of emotion. Journal of Cognitive Neuroscience, 14(8), 1215-29.
91. Ongur, D., Drevets, W. C., and Price, J. L. (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Science USA, 95(22), 13290-95.
92. Ongur, D., Ferry, A. T., and Price, J. L. (2003). Architectonic subdivision of the human orbital and medial prefrontal cortex. Journal of Comparitive Neurology, 460(3), 425-49.
93. Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S. et al. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience, 8(6), 828-34.
94. Phelps, E. A., and LeDoux, J. E. (2005). Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron, 48(2), 175-87.
95. Phillips, M. L., Drevets, W. C., Rauch, S. L., and Lane, R. (2003a). Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biological Psychiatry, 54, 504-14.
96. Phillips, M. L., Drevets, W. C., Rauch, S. L., and Lane, R. (2003b). Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biological Psychiatry, 54(5), 515-28.
97. Purcell, R., Maruff, P., Kyrios, M., and Pantelis, C. (1997). Neuropsychological function in young patients with unipolar major depression. Psychological Medicine, 27(6), 1277-85.
98. Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y. et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry, 45(9), 1085-98.
99. Rajkowska, G., Halaris, A., and Selemon, L. D. (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry, 49(9), 741-52.
100. Reneman, L., de Win, M. M., van den Brink, W., Booij, J., and den Heeten, G. J. (2006). Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology, 20(2), 164-75.
101. Ressler, K. J. and Mayberg, H. S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience, 10(9), 1116-24.
102. Ricaurte, G. A. and McCann, U. D. (2001). Assessing long-term effects of MDMA (ecstasy). Lancet, 358(9296), 1831-32.
103. Riedel, W. J., Klaassen, T., Deutz, N. E., van Someren, A., and van Praag, H. M. (1999). Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl), 141(4), 362-69.
104. Robbins, T. W. (2000). Chemical neuromodulation of frontalexecutive functions in humans and other animals. Experimental Brain Research, 133, 130-38.
105. Robinson, O. and Sahakian, B. J. (2008). Recurrence in major depressive disorder: a neurocognitive perspective. Psychological Medicine, 38, 315-18.
106. Robinson, O. and Sahakian, B. J. (2009). A double dissociation in the roles of serotonin and mood in healthy subjects. Biological Psychiatry, 65(1), 89-92.
107. Robinson, O., Cools, R., Crockett, M., and Sahakian, B. (2009). Mood state moderates the role of serotonin in cognitive biases. Journal of Psychopharmacology, 24(4), 573-83.
108. Rogers, R. D., Blackshaw, A. J., Middleton, H. C., Matthews, K., Hawtin, K., Crowley, C. et al. (1999). Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behavior. Psychopharmacology (Berl), 146(4), 482-91.
109. Rogers, R. D., Tunbridge, E. M., Bhagwagar, Z., Drevets, W. C., Sahakian, B. J., and Carter, C. S. (2003). Tryptophan depletion alters the decision making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology, 28(1), 153-62.
110. Roiser, J. P., Rubinsztein, J. S., and Sahakian, B. J. (2003). Cognition in depression. Psychiatry, 2, 43-47.
111. Roiser, J. P., Cook, L. J., Cooper, J. D., Rubinsztein, D. C., and Sahakian, B. J. (2005a). Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users. American Journal of Psychiatry, 162(3), 609-12.
112. Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I. et al. (2005b). The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacology, 30(4), 775-85.
113. Roiser, J. P., Blackwell, A. D., Cools, R., Clark, L., Rubinsztein, D. C., Robbins, T. W. et al. (2006). Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology, 31(10), 2264-72.
114. Roiser, J. P., Muller, U., Clark, L., and Sahakian, B. J. (2007). The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention. International Journal of Neuropsychopharmacology, 10(4), 449-61.
115. Roiser, J. P., Levy, J., Fromm, S. J., Wang, H., Hasler, G., Sahakian, B. J. et al. (2008). The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacology, 33(8), 1992-2006.
116. Rubinsztein, J. S., Michael, A., Paykel, E. S., and Sahakian, B. J. (2000). Cognitive impairment in remission in bipolar affective disorder. Psychological Medicine, 30(5), 1025-36.
117. Rubinsztein, J. S., Michael, A., Underwood, B. R., Tempest, M., and Sahakian, B. J. (2006). Impaired cognition and decision making in bipolar depression but no "affective bias" evident. Psychological Medicine, 36(5), 629-39.
118. Salkovskis, P. M. (1996). Frontiers of Cognitive Therapy. New York: Guilford Press.
119. Saxena, S., Brody, A. L., Ho, M. L., Zohrabi, N., Maidment, K. M., and Baxter, L. R., Jr. (2003). Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. American Journal of Psychiatry, 160(3), 522-32.
120. Schatzberg, A. F., Garlow, S. J., and Nemeroff, C. B. (2002). Molecular and cellular mechanisms in depression. In K. L. Davis, D. S. Charneym, J. T. Coyle and C. B. Nemeroff (eds), Neuropsychopharmacology. the fifth generation of progress (pp. 1039-50). Philadelphia: Lippincott, Williams and Wilkins.
121. Serretti, A., Benedetti, F., Zanardi, R., and Smeraldi, E. (2005). The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Progress in Neuropsychopharmacol Biological Psychiatry, 29(6), 1074-84.
122. Smith, K. A., Fairburn, C. G., and Cowen, P. J. (1997). Relapse of depression after rapid depletion of tryptophan. Lancet, 349(9056), 915-19.
123. Swainson, R., Rogers, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., and Robbins, T. W. (2000). Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia, 38(5), 596-612.
124. Sweeney, J. A., Kmiec, J. A., and Kupfer, D. J. (2000). Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biological Psychiatry, 48(7), 674-84.
125. Taylor Tavares, J. V., Drevets, W. C., and Sahakian, B. J. (2003). Cognition in mania and depression. Psychological Medicine, 33(6), 959-67.
126. Taylor Tavares, J. V., Clark, L., Cannon, D. M., Erickson, K., Drevets, W. C., and Sahakian, B. J. (2007). Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biological Psychiatry, 62(8), 917-24.
127. Taylor Tavares, J. V., Clark, L., Furey, M. L., Williams, G. B., Sahakian, B. J., and Drevets, W. C. (2008). Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage, 42(3), 1118-26.
128. Videbech, P. and Ravnkilde, B. (2004). Hippocampal volume and depression: a metaanalysis of MRI studies. American Journal of Psychiatry, 161(11), 1957-66.
129. Vrshek-Schallhorn, S., Wahlstrom, D., Benolkin, K., White, T., and Luciana, M. (2006). Affective bias and response modulation following tyrosine depletion in healthy adults. Neuropsychopharmacology, 31(11), 2523-36.
130. Weissman, M. M., Bland, R. C., Canino, G. J., Faravelli, C., Greenwald, S., Hwu, H. G. et al. (1996). Cross-national epidemiology of major depression and bipolar disorder. Jama, 276(4), 293-99.
131. WHO (2001). The World Health report: mental health: new understanding, new hope. Accessed April 1 2009.
132. Williams, W. A., Shoaf, S. E., Hommer, D., Rawlings, R., and Linnoila, M. (1999). Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. Journal of Neurochemistry, 72(4), 1641-47.
133. Wolfe, J., Granholm, E., Butters, N., Saunders, E., and Janowsky, D. (1987). Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients. Journal of Affective Disorders, 13(1), 83-92.
134. Yatham, L. N., Liddle, P. F., Shiah, I. S., Scarrow, G., Lam, R. W., Adam, M. J. et al. (2000). Brain serotonin2 receptors in major depression: a positron emission tomography study. Archives of General Psychiatry, 57(9), 850-58.
135. Zanardi, R., Serretti, A., Rossini, D., Franchini, L., Cusin, C., Lattuada, E. et al. (2001). Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biological Psychiatry, 50(5), 323-30.
136. Zarate, C. A., Jr., Tohen, M., Land, M., and Cavanagh, S. (2000). Functional impairment and cognition in bipolar disorder. Psychiatric Quarterly, 71(4), 309-29.